A-9758 targets and inhibits the activity of the RAR-related orphan receptors, which are nuclear receptors involved in the regulation of various biological processes including immune response, circadian rhythm, and metabolism. It targets IL-17A, IL-23, and IL-23.
Molecular Weight
527.36
Molecular Formula
C25H23Cl2F3N2O3
Targets
IL-17A; IL-23; IL-23: 5 nM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
A-9758 is employed in research to inhibit ROR receptors, examining its effects on immune response regulation and potential autoimmune disease therapy.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.